Ashley Crane, MD
Ophthalmology · Tampa, FLNPI 1225460371
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.5%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by AbbVie at 26.1% of the total. Among ophthalmology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 293 payments — averaging $128.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$10K
- Ocular Therapeutix, Inc.$7K
- Genentech USA, Inc.$7K
- Regeneron Healthcare Solutions, Inc.$2K
- Eyepoint US, Inc.$2K
- Alimera Sciences, Inc.$2K
- plus $8K from 24 others
Across 114 payments — averaging $4100.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$252K
- Ocular Therapeutix, Inc.$206K
- Eyepoint US, Inc.$9K
What the payments were for
- Consulting fees$19,80053%
- Speaking & faculty fees$1,2863%
- Travel & lodging$9473%
- Food & beverage$15,65142%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $9,848 |
| Ocular Therapeutix, Inc. | 8 | $7,051 |
| Genentech USA, Inc. | 57 | $6,730 |
| Regeneron Healthcare Solutions, Inc. | 54 | $2,018 |
| Eyepoint US, Inc. | 6 | $1,927 |
| Alimera Sciences, Inc. | 13 | $1,634 |
| Alcon | 15 | $1,412 |
| Harrow Eye, LLC | 15 | $1,132 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 10 | $644 |
| Astellas Pharma US Inc | 14 | $598 |
| Amgen | 5 | $561 |
| Apellis Pharmaceuticals, Inc. | 10 | $549 |
| Sun Pharmaceutical Industries Inc. | 6 | $488 |
| Regeneron | 6 | $481 |
| Novartis | 11 | $470 |
| Dutch Ophthalmic, USA | 5 | $416 |
| Glaukos Corporation | 4 | $376 |
| Sandoz | 6 | $192 |
| NEW World Medical,inc. | 1 | $142 |
| Tarsus Pharmaceuticals, Inc. | 1 | $137 |
| Hoffmann-la Roche Limited | 1 | $133 |
| Kala Pharmaceuticals, Inc. | 1 | $125 |
| Dompe US, Inc. | 1 | $122 |
| Sight Sciences, Inc. | 1 | $120 |
| ANI Pharmaceuticals, Inc. | 3 | $94 |
| Notal Vision, Inc. | 1 | $86 |
| Coherus Oncology, Inc. | 4 | $79 |
| Bausch & Lomb Americas Inc. | 3 | $65 |
| Mallinckrodt Hospital Products Inc. | 2 | $40 |
| Biogen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$37,683 in reported general payments places this provider in the 90th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 104 | $4,409 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 96 | $899 |
| Ketorolac Tromethamine | 26 | $885 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 32 | $332 |
| Brimonidine Tartrate | 26 | $221 |
| Gentamicin Sulfate | 11 | $159 |
| Timolol Maleate | 19 | $121 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Tampa
- Courtney BoveeTampa$796K
- Ivan SunerTampa$378K
- Pedram HamrahTampa$187K
- Thomas NewsomTampa$186K
- Don PerezTampa$178K
- Brian SzaboTampa$86K
- Cathleen McCabeBradenton$2M
- Daniel KiernanSarasota$1.7M
- David EichenbaumSt Petersburg$1.7M
- Mark MilnerPalm Beach Gardens$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.